Skip to content
goodwin-final-color Color Goodwin logo
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill and Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Biotechnology Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • About
    • Who We Are
    • Leadership
    • Board of Directors
    • Facilities and Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • Goodwin Biotechnology in the News
      • Press Releases
      • Upcoming Events
      • In the News
      • Publications & Patents
    • Careers
  • Contact Us
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill and Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Biotechnology Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • About
    • Who We Are
    • Leadership
    • Board of Directors
    • Facilities and Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • Goodwin Biotechnology in the News
      • Press Releases
      • Upcoming Events
      • In the News
      • Publications & Patents
    • Careers
  • Contact Us

Press Releases

Home / Who We Are / Goodwin Biotechnology in the News / Press Releases
Darrin Schellin CEO

Goodwin Biotechnology Announces the Appointment of Darrin T. Schellin as Chief Executive Officer

  • February 16, 2022

Goodwin Biotechnology CEO Karl Pinto on Delivering Integrated Manufacturing Solutions for Complex Biopharmaceuticals

  • October 19, 2020

AST and Goodwin Biotechnology Partner on a GENiSYS® C20 Aseptic Small Batch Filling & Closing Machine

  • September 14, 2020

GigaGen Initiates Large-Scale Manufacturing of its First-in-Class Recombinant
Hyperimmune Drug for COVID-19, GIGA-2050

  • September 9, 2020

Goodwin Biotechnology Launches a Digitization Initiative by Investing in a Sophisticated Electronic Quality Solution

  • November 6, 2019

Goodwin Biotechnology Announces the Appointment of Kent Payne, Ph.D. and Brandon Price, Ph.D. to its Board of Directors

  • August 19, 2019

Goodwin Biotechnology Secures Significant Institutional Investment in New Round of Growth Capital Financing

  • April 22, 2019

Radimmune Therapeutics Selected Goodwin Biotechnology for Process Development through cGMP Manufacturing of their IgG Monoclonal Antibody and Conjugate.

  • November 14, 2018

Telix Pharmaceuticals Selects Goodwin Biotechnology as Manufacturing Scale‐up Partner

  • May 2, 2018

Goodwin Biotechnology was named “Biologics cGMP Manufacturer of the Year 2018” by Global Health & Pharma News

  • March 20, 2018
1 2 3 … 5 Next

1850 N.W. 69th Avenue Plantation, FL 33313 USA 954-321-5300

  • Facebook
  • Twitter
  • LinkedIn
  • Manufacturing Solutions
    • Analytical Method Development
    • Clinical GMP Manufacturing Services
    • Upstream Development
    • Downstream Development
    • Aseptic Fill and Finish
    • Bioconjugation
  • Support Solutions
    • Regulatory & CMC Support
    • Quality Control
    • Quality Assurance
    • Project Management
    • Biotechnology Consulting Services
    • Cell Line Development
  • Applications
    • COVID-19
    • Exosomes
    • Biosimilars & Biobetters
    • Multispecific Antibodies & Antibody Fragments
  • Who We Are
    • Leadership
    • Board of Directors
    • Facilities & Location
    • Why Goodwin Biotechnology?
    • Goodwin Awards
    • Collaborations & Partnerships
    • Goodwin Biotechnology in the News
    • Careers
    • Blog
© 2022 Goodwin Biotechnology Inc. All Rights Reserved.
  • Privacy Policy
  • Sitemap